HERCULES BIOVENTURE PARTNERS
Hercules Bioventure Partners, a California-based venture capital firm, serves customers across the United States.
HERCULES BIOVENTURE PARTNERS
Status:
Active
Similar Organizations
Fisk Ventures
Fisk Ventures is a venture capital firm that serves customers in the United States.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-03 | BlossomHill Therapeutics | Hercules Bioventure Partners investment in Series A - BlossomHill Therapeutics | 71 M USD |
| 2017-02-28 | Addex Therapeutics | Hercules Bioventure Partners investment in Post-IPO Equity - Addex Therapeutics | 3 M CHF |
| 2015-03-09 | Addex Therapeutics | Hercules Bioventure Partners investment in Post-IPO Equity - Addex Therapeutics | 2.8 M CHF |
| 2015-02-05 | Armetheon | Hercules Bioventure Partners investment in Series B - Armetheon | 24.3 M USD |
| 2014-08-28 | Armetheon | Hercules Bioventure Partners investment in Series A - Armetheon | 7 M USD |
More informations about "Hercules Bioventure Partners" on Search Engine
Hercules Bioventure Partners LLC - Company Profile and News
Hercules Bioventure Partners, LLC operates as a venture capital firm. The Company serves customers in the United States. Company profile page for Hercules Bioventure …See details»
Armetheon Closes $24 Million Series B Financing | Fierce Biotech
MENLO PARK, Calif., Feb. 5, 2015 -- Armetheon, Inc., a cardiovascular disease-focused, clinical stage, specialty biopharmaceutical company, today announced the successful …See details»
Hercules Bioventures Investor Profile: Portfolio & Exits - PitchBook
Hercules Bioventures was a Menlo Park, California based venture capital firm focused on investing in the healthcare, pharmaceuticals, biotechnology and life sciences industries. …See details»
Hercules Bioventures - BioCentury Company Profiles - BCIQ
Mar 5, 2021 Overview. Hercules Bioventures. BioCentury | Mar 1, 2024. Finance. Venture report: Orbis, Curve leap into launches. Plus new rounds for Kenai, BlossomHill and …See details»
Armetheon Closes $24 Million Series B Financing - PR Newswire
Feb 5, 2015 Hsu is the founder and former President and CEO of Impax Laboratories, and a general partner at both Capital TEN II and Hercules Bioventure Partners. Mr. …See details»
Armetheon Records $24.3M Series B | PitchBook
Armetheon, a cardiovascular disease-focused biopharmaceutical company, has received a Series B investment totaling $24.3 million led by Hercules Bioventure Partners and …See details»
Armetheon inks $24.3 mln Series B
San Francisco Bay area-based Armetheon, a cardiovascular disease-focused biopharmaceutical company, has raised $24.3 million in Series B funding. Hercules …See details»
BioCentury - Armetheon raises $24.3M in series B
Feb 6, 2015 Armetheon Inc. (Menlo Park, Calif.) raised $24.3 million in a series B round led by existing investor Hercules Bioventure Partners and new investor Capital TEN II. …See details»
Our Team – BlossomHill Therapeutics, Inc.
George J. Lee, Ph.D. is a general partner and co-founder of Hercules Bioventure Partners, LLC, a venture management company specializing in investments in the …See details»
Hercules BioVentures Partners - CB Insights
Mar 30, 2017 Hercules BioVentures Partners is a California-based venture capital firm. Use the CB Insights Platform to explore Hercules BioVentures Partners's full profile.See details»
Bioventure Partners | LinkedIn
About us. Investment and Growth Advisory for high-impact technology driven (science/engineering/software) companies. Market: Life Science, Medical Device, and …See details»
VC firm Pivotal closes second $389M therapeutics fund to create ...
Dec 18, 2023 Senior Reporter. Pivotal bioVenture Partners Fund II has fully closed at $389 million, and the Bay Area firm still has more than 75% of that funding to deploy …See details»
Hercules Bioventure Partners - Unicorn Nest
0.40. Exits 1. Key employees Soon. Saratoga, California, United States. Areas of investment. Pharmaceutical. Biotechnology. Biopharma. Health Care. Medical. Related …See details»
In Second Fund, Pivotal Raises $389M to Create and Support ...
Dec 18, 2023 San Francisco – based venture capital firm Pivotal bioVenture Partners announced Monday it has closed its second fund, counting $389 million in capital …See details»
Armetheon Closes $24 Million Series B Financing | BioSpace
Feb 5, 2015 Hsu is the founder and former President and CEO of Impax Laboratories, and a general partner at both Capital TEN II and Hercules Bioventure Partners. Mr. …See details»
Hero's Bridge Village - Hero's Bridge - Services for Aging Veterans
Mar 11, 2024 Hero’s Bridge Village will be first of its kind community dedicated exclusively to aging veterans to lift our aging veterans out of substandard living conditions and …See details»
Hero's Bridge | Our Programs Are Supporting Aging Veterans
A thorough Quality of Life assessment is performed, and personalized frequency of visits established. Referrals will be made to the other programs of Hero’s Bridge ®, VA …See details»
HOME | Neatly Ever After
At Neatly Ever After, we are committed to creating custom organizational systems that target the challenging areas of your home. We leave you with organizational solutions …See details»
Contact Us - Hero's Bridge
Contact Us - Hero's Bridge. For more information please complete and submit this form, or call 540-341-5378. Our mailing address: 98 Alexandria Pike, Suite 41. Warrenton, VA …See details»